BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Q, Zhang W, Wu Z, Tian X, Xiang J, Li L, Li Z, Peng X, Wei S, Ma X, Zhao Y. Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects. Pharmacol Res 2021;165:105444. [PMID: 33493657 DOI: 10.1016/j.phrs.2021.105444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sheng W, Ji G, Zhang L. The Effect of Lithocholic Acid on the Gut-Liver Axis. Front Pharmacol 2022;13:910493. [DOI: 10.3389/fphar.2022.910493] [Reference Citation Analysis]
2 Zhang H, Li X, Wang J, Cheng Q, Shang Y, Wang G. Baicalin relieves Mycoplasma pneumoniae infection‑induced lung injury through regulating microRNA‑221 to inhibit the TLR4/NF‑κB signaling pathway. Mol Med Rep 2021;24:571. [PMID: 34109422 DOI: 10.3892/mmr.2021.12210] [Reference Citation Analysis]
3 He Q, Sun X, Zhang M, Chu L, Zhao Y, Wu Y, Zhang J, Han X, Guan S, Ding C. Protective effect of baicalin against arsenic trioxide-induced acute hepatic injury in mice through JAK2/STAT3 signaling pathway. Int J Immunopathol Pharmacol 2022;36:20587384211073397. [PMID: 35088608 DOI: 10.1177/20587384211073397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang J, Feng Q. Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease. Front Pharmacol 2022;13:854674. [DOI: 10.3389/fphar.2022.854674] [Reference Citation Analysis]
5 Wei J, Liu R, Zhang J, Liu S, Yan D, Wen X, Tian X. Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption. Front Pharmacol 2021;12:761763. [PMID: 34819863 DOI: 10.3389/fphar.2021.761763] [Reference Citation Analysis]
6 Ganguly R, Gupta A, Pandey AK. Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review. World J Gastroenterol 2022; 28(26): 3047-3062 [DOI: 10.3748/wjg.v28.i26.3047] [Reference Citation Analysis]
7 Wang X, Wan W, Lu J, Zhang Y, Quan G, Pan X, Wu Z, Liu P. Inhalable cryptotanshinone spray-dried swellable microparticles for pulmonary fibrosis therapy by regulating TGF-β1/Smad3, STAT3 and SIRT3 pathways. Eur J Pharm Biopharm 2022:S0939-6411(22)00033-9. [PMID: 35202797 DOI: 10.1016/j.ejpb.2022.02.012] [Reference Citation Analysis]
8 Dai X, Feng J, Chen Y, Huang S, Shi X, Liu X, Sun Y. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chin Med 2021;16:68. [PMID: 34344394 DOI: 10.1186/s13020-021-00469-4] [Reference Citation Analysis]
9 Zhao S, Huang M, Yan L, Zhang H, Shi C, Liu J, Zhao S, Liu H, Wang B, Diomede F. Exosomes Derived from Baicalin-Pretreated Mesenchymal Stem Cells Alleviate Hepatocyte Ferroptosis after Acute Liver Injury via the Keap1-NRF2 Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/8287227] [Reference Citation Analysis]
10 Li X, Li S, Ma C, Li T, Yang L. Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia. Drug Deliv 2022;29:1282-98. [PMID: 35467483 DOI: 10.1080/10717544.2022.2064564] [Reference Citation Analysis]
11 Li S, Yang Q, Zhou Z, Yang X, Liu Y, Hao K, Fu M. Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway. Bioengineered 2022;13:12625-36. [PMID: 35609324 DOI: 10.1080/21655979.2022.2076499] [Reference Citation Analysis]
12 Huang YT, Liang QQ, Zhang HR, Chen SY, Xu LH, Zeng B, Xu R, Shi FL, Ouyang DY, Zha QB, He XH. Baicalin inhibits necroptosis by decreasing oligomerization of phosphorylated MLKL and mitigates caerulein-induced acute pancreatitis in mice. Int Immunopharmacol 2022;108:108885. [PMID: 35623294 DOI: 10.1016/j.intimp.2022.108885] [Reference Citation Analysis]
13 Hu Q, Qu C, Xiao X, Zhang W, Jiang Y, Wu Z, Song D, Peng X, Ma X, Zhao Y. Flavonoids on diabetic nephropathy: advances and therapeutic opportunities. Chin Med 2021;16:74. [PMID: 34364389 DOI: 10.1186/s13020-021-00485-4] [Reference Citation Analysis]
14 Xia T, Li J, Ren X, Liu C, Sun C. Research progress of phenolic compounds regulating IL-6 to exert antitumor effects. Phytother Res 2021. [PMID: 34427003 DOI: 10.1002/ptr.7258] [Reference Citation Analysis]
15 Cao YJ, Li HZ, Zhao J, Sun YM, Jin XW, Lv SQ, Luo JY, Fang XX, Wen WB, Liao JB. Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics. Evid Based Complement Alternat Med 2022;2022:2264394. [PMID: 35845577 DOI: 10.1155/2022/2264394] [Reference Citation Analysis]
16 Zhang M, Hu R, Huang Y, Zhou F, Li F, Liu Z, Geng Y, Dong H, Ma W, Song K, Song Y. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota. Front Endocrinol 2022;13:933110. [DOI: 10.3389/fendo.2022.933110] [Reference Citation Analysis]
17 Wan F, Wang M, Zhong R, Chen L, Han H, Liu L, Zhao Y, Lv H, Hou F, Yi B, Zhang H. Supplementation With Chinese Medicinal Plant Extracts From Lonicera hypoglauca and Scutellaria baicalensis Mitigates Colonic Inflammation by Regulating Oxidative Stress and Gut Microbiota in a Colitis Mouse Model. Front Cell Infect Microbiol 2021;11:798052. [PMID: 35059326 DOI: 10.3389/fcimb.2021.798052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang X, Xie L, Long J, Liu K, Lu J, Liang Y, Cao Y, Dai X, Li X. Therapeutic effect of baicalin on inflammatory bowel disease: A review. J Ethnopharmacol 2022;283:114749. [PMID: 34666140 DOI: 10.1016/j.jep.2021.114749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]